This media is in the public domain (free of copyright restrictions). You can copy, modify, and distribute this work without contacting the Smithsonian. For more information, visit the Smithsonian's ...

LTS-101 is a one-time AAV gene therapy candidate intended to provide durable expression of the TPP1 enzyme in the central nervous system (CNS) of children with CLN2 disease FDA designations underscore ...

Announcing the passing of a loved one in local news media is a long standing tradition and we are proud of the trust placed in us to make these important announcements. Every notice published to our ...

NEW YORK – The US Food and Drug Administration has approved Latus Bio's investigational new drug application, allowing the firm to begin clinical trials of a gene therapy candidate in patients with ...

Offer available to new subscribers only. Plus tax where applicable, see payment page for details.

Get pick by pick results from each round of the 2021 NFL Draft with Draftcast on ESPN ...